The study highlights the unmet need for effective strategies to prevent chemotherapy‑induced nerve damage, which affects long ...

Oct 24 (Reuters) - A newer class of cancer drugs can delay disease progression or extend survival for breast cancer patients, multiple teams of researchers reported at a major European oncology ...

Platinum-based chemotherapy is a standard treatment for ovarian cancer, but its effectiveness can be limited in some cases.

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

A pill therapy tested at Roswell Park Comprehensive Cancer Center has shown marked survival improvements for advanced pancreatic cancer patients in early research. Involving over 500 participants ...

SP16 is an investigational intravenous therapy designed to treat chemotherapy-induced pain and peripheral neuropathy, also ...

The findings build on data suggesting Revolution’s therapy could upend treatment for a notoriously tough-to-treat tumor and ...

President, C.P. Radhakrishnan, on Saturday emphasised that mental resilience is key in the fight against cancer and urged ...

A multi-center phase 2 trial found that adding the experimental drug elraglusib to standard chemotherapy extended survival for patients with metastatic pancreatic ductal adenocarcinoma. Conducted ...